Electroceuticals/Bioelectric Medicine Market Analysis and Forecast to 2031: By Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Spinal Cord Stimulators, Cochlear Implants, Deep Brain Stimulators, Sacral Nerve Stimulators & Gastric El
Description
Electroceuticals/Bioelectric Medicine Market Analysis and Forecast to 2031: By Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Spinal Cord Stimulators, Cochlear Implants, Deep Brain Stimulators, Sacral Nerve Stimulators & Gastric Electric Stimulators, Vagus Nerve Stimulators, Others), Type (Implantable Electroceutical Devices, Noninvasive Electroceutical Devices), End User (Hospitals, Clinics, and ASC’s, Others), and Region
The global electroceuticals/bioelectric medicine market was valued at USD 17.2 billion in 2021 and it is expected to reach up to USD 27.9 billion by 2031, at a CAGR of 5.0% during the forecast period.
Numerous neurological illnesses, including Parkinson's illness, obsessive compulsive disorder (OCD), epilepsy, Alzheimer's illness, dystonia, and essential tremor, are currently being treated with electro pharmaceutical devices or bioelectric therapy. It is useful in the diagnosis and treatment of all neurological illnesses involving the autonomic, somatic, and central nervous systems as well as their subsystems.
Global Electroceuticals/Bioelectric Medicine Market Scope and Report Structure
Market Trends and Drivers
Neurologic or cardiovascular problems are more likely to affect the elderly population. Geriatrics make up a significant portion of the patient population due to their higher risk of developing these ailments. Therefore, as this demographic segment expands, there will be an increased need for electroceutical devices such spinal cord stimulators, implantable cardioverter defibrillators, deep brain stimulators, and cardiac pacemakers to treat neurological and cardiovascular conditions.
Likewise, Major market participants have significant prospects for growth in emerging economies such those in India, South Korea, Malaysia, Vietnam, Africa, and the Middle East including Israel, Saudi Arabia, and the United Arab Emirates. This can be ascribed to their lax regulatory requirements, advancements in the healthcare system, increasing patient populations, and rising healthcare costs. Additionally, compared to wealthy nations, the Asia-Pacific area has more flexible and business-friendly regulatory frameworks. Key participants in the electroceuticals/bioelectric medicine market are now concentrating on emerging nations as a result of this as well as the escalating rivalry in mature markets.
Market Restraints and Challenges
Especially in price-sensitive regions like the Asia Pacific, Latin America, and Africa, the high cost of electroceutical devices like cochlear implants and neurostimulators is a major problem impeding market expansion. Healthcare providers, particularly in developing nations like Brazil and Mexico, lack the financial resources to make complex technological investments. Additionally, the crew needs intensive training in order to maintain and handle electroceutical devices effectively. To develop technologically cutting-edge electroceutical products like cochlear implants, considerable R&D operations are necessary. The cost of production consequently rises significantly as a result. As a result, only established or significant market participants can afford the enormous financial investments needed to carry out such activities.
Global Electroceutical/Bioelectronic Medicine Market Segmental Overview
The report analyses the electroceutical/bioelectronic medicine market based on product, type, end user, and regions.
Global Electroceutical/Bioelectronic Medicine Market by Product
Based on product, it is segmented into cardiac pacemakers & implantable cardioverter defibrillators, spinal cord stimulators, cochlear implants, deep brain stimulators, transcutaneous electrical nerve stimulators, vagus nerve stimulators, sacral nerve stimulators & gastric electrical stimulators, and others. The cardiac pacemakers & implantable cardioverter defibrillators accounted for the largest share of the market. The key factors boosting the growth of the market are the rising incidence of arrhythmias coupled with the rising prevalence of CVD, and rising technological advancements.
Global Electroceutical/Bioelectronic Medicine Market by Type
By type, it is segmented into implantable electroceutical devices and noninvasive electroceutical devices. The implantable electroceutical devices segment accounted for the largest share of the market. The key factors such as increasing incidences of neurological & cardiovascular disorders and an increase in the number of product approvals are boosting the growth of the market.
Global Electroceutical/Bioelectronic Medicine Market by End User
By end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals, clinics, and ambulatory surgical centers segment is likely to dominate the market during the forecast period. The factors boosting the growth of the market are the increasing adoption of electroceutical devices to serve a large patient pool.
Geographical Analysis of Global Electroceutical/Bioelectronic Medicine Market
Based on region, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is the largest regional market for the electroceutical/bioelectronic medicine market. The key factors such as the highly developed healthcare system in the US and Canada, increasing healthcare spending, and the increasing prevalence of cardiovascular & neurological disorders are boosting the growth of the market.
Major Players in the Global Electroceutical/Bioelectronic Medicine Market
COVID-19 Impact
The global delivery of healthcare has changed as a result of the COVID-19 epidemic. Numerous hospitals and departments have been re-profiled for caring for patients with COVID-19 as a result of the increasing demand brought on by the rising prevalence of COVID-19 hospitalizations. Due to the restricted capacity and resources (such as hospital beds and patient care specialists) available, many elective surgeries were either postponed or cancelled throughout the world. Additionally, there is a greater inclination for remote monitoring as a result of the COVID-19 outbreak. Tech businesses, healthcare organisations, and individuals are more intrigued by remote medical technologies like wireless pacemakers and non-invasive electroceuticals that let doctors consult with patients from a distance. These tools could be helpful during the pandemic for a number of reasons, including their capacity to identify unrecognised heart conditions in individuals skipping routine check-ups and their utility in examining COVID-19 patients' reactions to heart-related experimental drugs. The epidemic has also affected how remote monitoring devices are approved. In response to this epidemic, the FDA updated its approval guidelines. Current non-invasive patient monitoring technology has been used in this public health emergency to limit the need for unnecessary patient contact and the strain on healthcare institutions. It is anticipated that these discoveries will encourage the use of non-invasive or minimally invasive electroceutical devices.
Recent Developments
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
The global electroceuticals/bioelectric medicine market was valued at USD 17.2 billion in 2021 and it is expected to reach up to USD 27.9 billion by 2031, at a CAGR of 5.0% during the forecast period.
Numerous neurological illnesses, including Parkinson's illness, obsessive compulsive disorder (OCD), epilepsy, Alzheimer's illness, dystonia, and essential tremor, are currently being treated with electro pharmaceutical devices or bioelectric therapy. It is useful in the diagnosis and treatment of all neurological illnesses involving the autonomic, somatic, and central nervous systems as well as their subsystems.
Global Electroceuticals/Bioelectric Medicine Market Scope and Report Structure
Market Trends and Drivers
Neurologic or cardiovascular problems are more likely to affect the elderly population. Geriatrics make up a significant portion of the patient population due to their higher risk of developing these ailments. Therefore, as this demographic segment expands, there will be an increased need for electroceutical devices such spinal cord stimulators, implantable cardioverter defibrillators, deep brain stimulators, and cardiac pacemakers to treat neurological and cardiovascular conditions.
Likewise, Major market participants have significant prospects for growth in emerging economies such those in India, South Korea, Malaysia, Vietnam, Africa, and the Middle East including Israel, Saudi Arabia, and the United Arab Emirates. This can be ascribed to their lax regulatory requirements, advancements in the healthcare system, increasing patient populations, and rising healthcare costs. Additionally, compared to wealthy nations, the Asia-Pacific area has more flexible and business-friendly regulatory frameworks. Key participants in the electroceuticals/bioelectric medicine market are now concentrating on emerging nations as a result of this as well as the escalating rivalry in mature markets.
Market Restraints and Challenges
Especially in price-sensitive regions like the Asia Pacific, Latin America, and Africa, the high cost of electroceutical devices like cochlear implants and neurostimulators is a major problem impeding market expansion. Healthcare providers, particularly in developing nations like Brazil and Mexico, lack the financial resources to make complex technological investments. Additionally, the crew needs intensive training in order to maintain and handle electroceutical devices effectively. To develop technologically cutting-edge electroceutical products like cochlear implants, considerable R&D operations are necessary. The cost of production consequently rises significantly as a result. As a result, only established or significant market participants can afford the enormous financial investments needed to carry out such activities.
Global Electroceutical/Bioelectronic Medicine Market Segmental Overview
The report analyses the electroceutical/bioelectronic medicine market based on product, type, end user, and regions.
Global Electroceutical/Bioelectronic Medicine Market by Product
Based on product, it is segmented into cardiac pacemakers & implantable cardioverter defibrillators, spinal cord stimulators, cochlear implants, deep brain stimulators, transcutaneous electrical nerve stimulators, vagus nerve stimulators, sacral nerve stimulators & gastric electrical stimulators, and others. The cardiac pacemakers & implantable cardioverter defibrillators accounted for the largest share of the market. The key factors boosting the growth of the market are the rising incidence of arrhythmias coupled with the rising prevalence of CVD, and rising technological advancements.
Global Electroceutical/Bioelectronic Medicine Market by Type
By type, it is segmented into implantable electroceutical devices and noninvasive electroceutical devices. The implantable electroceutical devices segment accounted for the largest share of the market. The key factors such as increasing incidences of neurological & cardiovascular disorders and an increase in the number of product approvals are boosting the growth of the market.
Global Electroceutical/Bioelectronic Medicine Market by End User
By end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals, clinics, and ambulatory surgical centers segment is likely to dominate the market during the forecast period. The factors boosting the growth of the market are the increasing adoption of electroceutical devices to serve a large patient pool.
Geographical Analysis of Global Electroceutical/Bioelectronic Medicine Market
Based on region, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is the largest regional market for the electroceutical/bioelectronic medicine market. The key factors such as the highly developed healthcare system in the US and Canada, increasing healthcare spending, and the increasing prevalence of cardiovascular & neurological disorders are boosting the growth of the market.
Major Players in the Global Electroceutical/Bioelectronic Medicine Market
COVID-19 Impact
The global delivery of healthcare has changed as a result of the COVID-19 epidemic. Numerous hospitals and departments have been re-profiled for caring for patients with COVID-19 as a result of the increasing demand brought on by the rising prevalence of COVID-19 hospitalizations. Due to the restricted capacity and resources (such as hospital beds and patient care specialists) available, many elective surgeries were either postponed or cancelled throughout the world. Additionally, there is a greater inclination for remote monitoring as a result of the COVID-19 outbreak. Tech businesses, healthcare organisations, and individuals are more intrigued by remote medical technologies like wireless pacemakers and non-invasive electroceuticals that let doctors consult with patients from a distance. These tools could be helpful during the pandemic for a number of reasons, including their capacity to identify unrecognised heart conditions in individuals skipping routine check-ups and their utility in examining COVID-19 patients' reactions to heart-related experimental drugs. The epidemic has also affected how remote monitoring devices are approved. In response to this epidemic, the FDA updated its approval guidelines. Current non-invasive patient monitoring technology has been used in this public health emergency to limit the need for unnecessary patient contact and the strain on healthcare institutions. It is anticipated that these discoveries will encourage the use of non-invasive or minimally invasive electroceutical devices.
Recent Developments
- March 2022, Feinstein Institutes, Spark Biomedical, Inc. collaborate to advance bioelectric medicine.
- March 2021, Medtronic Plc received US FDA approval for its Intellis Platform with Differential Target Multiplexed (DTM) programming to treat chronic intractable back and leg pain.
- January 2021, Boston Scientific Corporation received US FDA approval for its Vercise Genus Deep Brain Stimulation System.
- January 2020, Medtronic Plc acquired Stimgenics, LLC, a novel spinal cord stimulation therapy.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
189 Pages
- Chapter 1. Market Introduction
- 1.1. Objectives of the study
- 1.2. Market definition and research & scope
- 1.3. Research methodologies
- 1.4. Market estimation techniques
- Chapter 2. Executive Summary
- 2.1. Summary
- 2.2. Key highlights of the market
- Chapter 3. Electroceuticals/Bioelectric Medicine Market Outlook
- 3.1. Electroceuticals/Bioelectric Medicine market segmentation
- 3.2. Market dynamics
- 3.2.1. Market drivers
- 3.2.1.1. Driver 1
- 3.2.1.2. Driver 2
- 3.2.1.3. Driver 3
- 3.2.2. Market restraints
- 3.2.2.1. Restraint 1
- 3.2.2.2. Restraint 2
- 3.2.3. Market opportunities
- 3.2.3.1. Opportunity 1
- 3.2.3.2. Opportunity 2
- 3.3. Porter’s five forces analysis
- 3.3.1. Threat of new entrants
- 3.3.2. Threat of substitutes
- 3.3.3. Bargaining power of buyers
- 3.3.4. Bargaining power of supplier
- 3.3.5. Competitive rivalry
- 3.4. Pestle analysis
- 3.5. Value chain analysis
- 3.5.1. Raw material suppliers
- 3.5.2. Manufacturers
- 3.5.3. Wholesalers and/or retailers
- 3.6. Impact of the Russia and Ukraine war on the global Electroceuticals/Bioelectric Medicine market
- Chapter 4. The Economic Impact of Covid-19
- 4.1. Overall impact of covid-19
- 4.2. Impact of covid on the global Electroceuticals/Bioelectric Medicine market
- 4.3. Economic impact analysis
- Chapter 5. Electroceuticals/Bioelectric Medicine Market by Product
- 5.1. Market overview
- 5.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
- 5.2.1. Market size and forecast, 2021-2031 ($million)
- 5.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.3. Spinal Cord Stimulators
- 5.3.1. Market size and forecast, 2021-2031 ($million)
- 5.3.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.4. Cochlear Implants
- 5.4.1. Market size and forecast, 2021-2031 ($million)
- 5.4.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.5. Deep Brain Stimulators
- 5.5.1. Market size and forecast, 2021-2031 ($million)
- 5.5.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.6. Sacral Nerve Stimulators & Gastric Electrical Stimulators
- 5.6.1. Market size and forecast, 2021-2031 ($million)
- 5.6.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.7. Vagus Nerve Stimulators
- 5.7.1. Market size and forecast, 2021-2031 ($million)
- 5.7.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.8. Others
- 5.8.1. Market size and forecast, 2021-2031 ($million)
- 5.8.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 6. Electroceuticals/Bioelectric Medicine Market by Type
- 6.1. Market overview
- 6.2. Implantable Electroceutical Devices
- 6.2.1. Market size and forecast, 2021-2031 ($million)
- 6.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 6.3. Noninvasive Electroceutical Devices
- 6.3.1. Market size and forecast, 2021-2031 ($million)
- 6.3.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 7. Electroceuticals/Bioelectric Medicine Market by End Users
- 7.1. Market overview
- 7.2. Hospitals, Clinics, and ASCs
- 7.2.1. Market size and forecast, 2021-2031 ($million)
- 7.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 7.3. Others
- 7.3.1. Market size and forecast, 2021-2031 ($million)
- 7.3.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 8. Global Electroceuticals/Bioelectric Medicine Market, by Region
- 8.1. Overview
- 8.2. North America
- 8.2.1. Key market trends and opportunities
- 8.2.2. North America Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.2.3. North America Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.2.4. North America Electroceuticals/Bioelectric Medicine market size and forecast by country, 2021-2031, ($million)
- 8.2.5. The u.s.
- 8.2.5.1. The u.s. Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.2.5.2. The u.s. Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.2.6. Canada
- 8.2.6.1. Canada Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.2.6.2. Canada Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.2.7. Mexico
- 8.2.7.1. Mexico Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.2.7.2. Mexico Electroceuticals/Bioelectric Medicine market size and forecast by End User Product, 2021-2031, ($million)
- 8.3. Europe
- 8.3.1. Key market trends and opportunities
- 8.3.2. Europe Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.3.3. Europe Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.3.4. Europe Electroceuticals/Bioelectric Medicine market size and forecast by country, 2021-2031, ($million)
- 8.3.5. Germany
- 8.3.5.1. Germany Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.3.5.2. Germany Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.3.6. France
- 8.3.6.1. France Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.3.6.2. France Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.3.7. U.K.
- 8.3.7.1. U.K. Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.3.7.2. U.K. Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.3.8. Spain
- 8.3.8.1. Spain Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.3.8.2. Spain Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.3.9. Italy
- 8.3.9.1. Italy Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.3.9.2. Italy Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.3.10. Russia
- 8.3.10.1. Russia Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.3.10.2. Russia Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.3.11. Rest of Europe
- 8.3.11.1. Rest of Europe Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.3.11.2. Rest of Europe Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.4. Asia-pacific
- 8.4.1. Key market trends and opportunities
- 8.4.2. Asia-pacific Electroceuticals/Bioelectric Medicine market size and forecast by country, 2021-2031, ($million)
- 8.4.3. Asia-pacific Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.4.4. Asia-pacific Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.4.5. China
- 8.4.5.1. China Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.4.5.2. China Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.4.6. India
- 8.4.6.1. India Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.4.6.2. India Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.4.7. Japan
- 8.4.7.1. Japan Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.4.7.2. Japan Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.4.8. South Korea
- 8.4.8.1. South Korea Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.4.8.2. South Korea Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.4.9. Rest of APAC
- 8.4.9.1. Rest of APAC Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.4.9.2. Rest of APAC Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.5. Rest of the world
- 8.5.1. Key market trends and opportunities
- 8.5.2. Rest of the world Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.5.3. Rest of the world Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.5.4. Rest of the world Electroceuticals/Bioelectric Medicine market size and forecast by country, 2021-2031, ($million)
- 8.5.5. Latin America
- 8.5.5.1. Latin America Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.5.5.2. Latin America Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.5.6. Middle east
- 8.5.6.1. Middle east Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.5.6.2. Middle east Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- 8.5.7. Africa
- 8.5.7.1. Africa Electroceuticals/Bioelectric Medicine market size and forecast by Product, 2021-2031, ($million)
- 8.5.7.2. Africa Electroceuticals/Bioelectric Medicine market size and forecast by End User, 2021-2031, ($million)
- Chapter 9. Competitive Landscape
- 9.1. Market overview
- 9.2. Market share analysis/key player positioning
- 9.3. Developmental strategy benchmarking
- 9.3.1. New End User development
- 9.3.2. Product launches
- 9.3.3. Business expansions
- 9.3.4. Partnerships, joint ventures, and collaborations
- 9.3.5. Mergers and acquisitions
- Chapter 10. Company Profiles
- 10.1. Medtronic plc (Ireland)
- 10.1.1. Company snapshot
- 10.1.2. Financial performance
- 10.1.3. Product offerings
- 10.1.4. Key strategic initiatives
- 10.1.5. SWOT analysis
- 10.2. Boston Scientific Corporation (US)
- 10.2.1. Company snapshot
- 10.2.2. Financial performance
- 10.2.3. Product offerings
- 10.2.4. Key strategic initiatives
- 10.2.5. SWOT analysis
- 10.3. Abbott Laboratories, Inc. (US)
- 10.3.1. Company snapshot
- 10.3.2. Financial performance
- 10.3.3. Product offerings
- 10.3.4. Key strategic initiatives
- 10.3.5. SWOT analysis
- 10.4. LivaNova PLC (UK)
- 10.4.1. Company snapshot
- 10.4.2. Financial performance
- 10.4.3. Product offerings
- 10.4.4. Key strategic initiatives
- 10.4.5. SWOT analysis
- 10.5. Cochlear Ltd. (Australia)
- 10.5.1. Company snapshot
- 10.5.2. Financial performance
- 10.5.3. Product offerings
- 10.5.4. Key strategic initiatives
- 10.5.5. SWOT analysis
- 10.6. MicroPort Scientific Corporation (China)
- 10.6.1. Company snapshot
- 10.6.2. Financial performance
- 10.6.3. Product offerings
- 10.6.4. Key strategic initiatives
- 10.6.5. SWOT analysis
- 10.7. Sonova Group (Switzerland)
- 10.7.1. Company snapshot
- 10.7.2. Financial performance
- 10.7.3. Product offerings
- 10.7.4. Key strategic initiatives
- 10.7.5. SWOT analysis
- 10.8. Nevro Corp. (US)
- 10.8.1. Company snapshot
- 10.8.2. Financial performance
- 10.8.3. Product offerings
- 10.8.4. Key strategic initiatives
- 10.8.5. SWOT analysis
- 10.9. Axonics Modulation Technologies, Inc. (US)
- 10.9.1. Company snapshot
- 10.9.2. Financial performance
- 10.9.3. Product offerings
- 10.9.4. Key strategic initiatives
- 10.9.5. SWOT analysis
- 10.10. Neuronetics, Inc. (US)
- 10.10.1. Company snapshot
- 10.10.2. Financial performance
- 10.10.3. Product offerings
- 10.10.4. Key strategic initiatives
- 10.10.5. SWOT analysis
- *the list of company is subject to change during the final compilation of the report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
